BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1378347)

  • 1. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes.
    Suarez-Roca H; Maixner W
    Brain Res; 1992 May; 579(2):195-203. PubMed ID: 1378347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Abdullah L; Zuniga J; Madison S; Maixner W
    Brain Res; 1992 May; 579(2):187-94. PubMed ID: 1378346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons.
    Suarez-Roca H; Maixner W
    Neurosci Lett; 1995 Jul; 194(1-2):41-4. PubMed ID: 7478208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways.
    Cabot PJ; Cramond T; Smith MT
    Pulm Pharmacol Ther; 1997 Aug; 10(4):215-21. PubMed ID: 9695145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo.
    Aimone LD; Yaksh TL
    Peptides; 1989; 10(6):1127-31. PubMed ID: 2482963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro.
    Ray NJ; Jones AJ; Keen P
    Br J Pharmacol; 1991 Apr; 102(4):797-800. PubMed ID: 1713104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal capsaicin treatment abolishes the modulations by opioids of substance P release from rat spinal cord slices.
    Pohl M; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neurosci Lett; 1989 Jan; 96(1):102-7. PubMed ID: 2467229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic modulation of synaptic transmission by opioid receptor in rat subthalamic nucleus in vitro.
    Shen KZ; Johnson SW
    J Physiol; 2002 May; 541(Pt 1):219-30. PubMed ID: 12015431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
    Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
    Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mu-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn.
    Aicher SA; Punnoose A; Goldberg A
    J Neurosci; 2000 Jun; 20(11):4345-54. PubMed ID: 10818170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers.
    Arcaya JL; Cano G; Gómez G; Maixner W; Suárez-Roca H
    Eur J Pharmacol; 1999 Jan; 366(1):27-34. PubMed ID: 10064148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid regulation of pallidal enkephalin release: bimodal effects of locally administered mu and delta opioid agonists in freely moving rats.
    Olive MF; Maidment NT
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1310-6. PubMed ID: 9618438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mu- and delta-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion.
    Rogers H; Henderson G
    Br J Pharmacol; 1990 Nov; 101(3):505-12. PubMed ID: 1981687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The K(+)-evoked release of [3H]acetylcholine from slices of rat globus pallidus: modulation by delta-opioid receptors.
    Ruzicka BB; Jhamandas K
    Can J Physiol Pharmacol; 1991 Mar; 69(3):414-8. PubMed ID: 1647849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
    Becker C; Hamon M; Cesselin F; Benoliel JJ
    Synapse; 1999 Oct; 34(1):47-54. PubMed ID: 10459171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
    Pinnock RD
    Brain Res; 1992 Jun; 583(1-2):237-46. PubMed ID: 1354563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.